Arca Biopharma

ABIO

1.15

-0.12

-9.8%

Premarket:

1.15

0.00

0.0%

Please Subscribe or Register

Login|Subscribe|Register

Stock Price
Open: 1.20
Prev. Close: 1.27
Low/Hi: 1.15 - 1.25
52-Week: 1.13 - 3.11
Volumes
Equity: 79,349
90-Day Avg: 131,368
Volatility
Todays Stock Vol: 117.6
20-Day (HV): 106.7
52-Week (HV): 68.9
Fundamental
Div. Yield: 0.0%
Earnings: 14-Nov (Est.)
P/E Ratio:
Market Cap: 13.5 M
Stock Type: Common
Sector: Healthcare
Industry: Biotechnology
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

ABIO Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Jun-2017 31-Mar-2017 31-Dec-2016 30-Sep-2016
Cash and Cash Equivalents 9,101 6,170 7,401 8,095
Short Term Investments 6,906 13,041 13,762 15,373
Investments - - - -
Accounts Receivable 0 0 0 0
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 0 0 0 0
Net Property Plant and Equipment 54 59 66 69
Other Current Assets 648 643 282 320
Current Assets 16,655 19,854 21,445 23,788
Goodwill and Intangibles 0 0 0 0
Long Term Investments 0 0 2,352 3,967
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 17,296 20,589 24,629 28,679
Short Term Debt 0 0 0 0
Other Non-Current Assets 587 676 766 855
Accounts Payable 1,072 980 1,205 1,141
Accrued Liabilities and Other Payables 1,447 1,538 1,191 1,015
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 2,549 2,553 2,435 2,199
Other Current Liabilities 0 0 0 0
Accumulated Other Comprehensive Income -5 -9 -19 -6
Preferred Stock 0 0 0 0
Current Liabilities 2,519 2,518 2,396 2,156
Common Stock 10 9 9 9
Other Non-Current Liabilities 30 35 39 43
Additional Paid-In Capital 137,113 134,885 134,715 134,744
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -122,371 -116,849 -112,511 -108,267
Total Equity 14,747 18,036 22,194 26,480
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Cash and Cash Equivalents 7,401 38,802 15,354 16,756
Short Term Investments 13,762 0 0 0
Investments - - - -
Accounts Receivable 0 0 0 0
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 0 0 0 0
Net Property Plant and Equipment 66 28 36 29
Other Current Assets 282 114 134 169
Current Assets 21,445 38,916 15,488 16,925
Goodwill and Intangibles 0 0 0 0
Long Term Investments 2,352 0 0 0
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 24,629 39,574 16,132 17,084
Short Term Debt 0 0 0 0
Other Non-Current Assets 766 630 608 130
Accounts Payable 1,205 364 795 597
Accrued Liabilities and Other Payables 1,191 1,140 593 905
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 2,435 1,504 1,391 1,503
Other Current Liabilities 0 0 0 0
Accumulated Other Comprehensive Income -19 0 0 0
Preferred Stock 0 0 0 0
Current Liabilities 2,396 1,504 1,388 1,502
Common Stock 9 9 21 16
Other Non-Current Liabilities 39 0 3 1
Additional Paid-In Capital 134,715 134,128 99,342 90,498
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -112,511 -96,067 -84,622 -74,933
Total Equity 22,194 38,070 14,741 15,581